Roche to complete acquisition of U.S. biopharma company Poseida
Why This Gene-Therapy Company's Stock Is Rising 228%
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Roche to acquire US-based Poseida Therapeutics